Results 61 to 70 of about 114,155 (256)
The Scientific World Journal, 2000 Nature and Science ran completely different news line-ups this week. But their lead stories agreed on one thing: patients matter. Nature led with a story about a group of patients who will share in a patent after giving blood and tissue samples to scientists.
openaire +3 more sources
Journal of International Clinical Dental Research Organization, 2017 This study was conducted to analyze the changes in gingival health in patients treated with probiotic containing mouth rinse. Thirty volunteers between 20 and 35 years were randomly divided into two groups.
Vikas Jindal +5 more
doaj +1 more source
, 2018 The use of placebos in medicine is an area of ethical questioning, but we often do not consider the effect of placebos on daily life. One’s preconceptions on the outcomes of exercise physically affect health. Studies show being aware of the advantages of
Cupp, Kelsey
core +1 more source
Minitablets may be an acceptable alternative to liquid in infants and young children [PDF]
, 2019 Klingmann V, Linderskamp H, Meissner T, Mayatepek E, Moeltner A, Breitkreutz J, et al. Acceptability of Multiple Uncoated Minitablets in Infants and Toddlers: A Randomized Controlled Trial. J Pediatr 2018;201:202-7.
Batchelor, Hannah
core +2 more sources
BMJ, 2011 Clinicians’ and family members’ feelings and perceptions about a treatment may influence their judgments about its ...
David J. Grelotti, Ted J. Kaptchuk
openaire +4 more sources
General Practitioners Attitudes towards Open-Label Placebos in Australia [PDF]
, 2018 This item is only available electronically.Objective: Multiple studies have found between 18-70% of medical professionals prescribe placebos, with general practitioners’ (GPs) reportedly being the highest prescribers.
Matthews, Kaitlin
core
Asthma as a Model for Placebo Effects in Modern Medicine [PDF]
, 2011 Many a clinical intervention thrives on placebos. Lack of consensus — both definitional and methodological — however, contributes to general confusion and specious conclusions regarding the legitimacy and relevance of placebos in modern medicine.
Delpero, Emily A +2 more
core +1 more source
Simultaneous confidence intervals for an extended Koch-Röhmel design in three-arm non-inferiority trials [PDF]
Stat Methods Med Res. 2023; 32(9):1784-1798, 2022 Three-arm `gold-standard' non-inferiority trials are recommended for indications where only unstable reference treatments are available and the use of a placebo group can be justified ethically. For such trials several study designs have been suggested that use the placebo group for testing 'assay sensitivity', i.e.
arxiv
Changing EDSS progression in placebo cohorts in relapsing MS: A systematic review and meta-regression [PDF]
PLoS ONE, 10(9):e0137052, 2015, 2013 Background: Recent systematic reviews of randomised controlled trials (RCTs) in relapsing multiple sclerosis (RMS) revealed a decrease in placebo annualized relapse rates (ARR) over the past two decades. Furthermore, regression to the mean effects were observed in ARR and MRI lesion counts.
arxiv +1 more source
From substance to process: A meta-ethnographic review of how healthcare professionals and patients understand placebos and their effects in primary care. [PDF]
, 2018 Research suggests that a 'placebo' can improve conditions common in primary care including pain, depression and irritable bowel syndrome. However, disagreement persists over the definition and clinical relevance of placebo treatments. We conducted a meta-
Bishop, F.L. +5 more
core +1 more source